| Serial Number | 79397609 |
| Word Mark | LILIUMX |
| Filing Date | Tuesday, March 5, 2024 |
| Status | 680 - APPROVED FOR PUBLICATION |
| Status Date | Friday, May 30, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Scientific and technological services and research and design relating thereto in the field of medicine; scientific research for medical purposes; research and development of vaccines and medicines; scientific research for medical purposes in the area of cancerous diseases; research and development services in the field of antibodies; drug discovery services; pharmaceutical drug development services; pharmaceutical products development; development of pharmaceutical preparations and medicines; pharmaceutical research and development; conducting clinical trials for pharmaceutical products; testing of pharmaceuticals; biochemistry drug discovery services; scientific laboratory services; medical research laboratory services; consultancy in the field of pharmaceutical research; consultancy relating to research and development in the field of therapeutics |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 13, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Valink Therapeutics Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | US |
| Event Date | Event Description |
| Thursday, June 13, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Wednesday, September 18, 2024 | ASSIGNED TO EXAMINER |
| Thursday, June 20, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, June 20, 2024 | APPLICATION FILING RECEIPT MAILED |
| Saturday, October 12, 2024 | NON-FINAL ACTION WRITTEN |
| Tuesday, October 15, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Tuesday, October 22, 2024 | REFUSAL PROCESSED BY MPU |
| Saturday, November 9, 2024 | REFUSAL PROCESSED BY IB |
| Tuesday, October 22, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Monday, April 21, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, April 21, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, April 22, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, May 29, 2025 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, May 29, 2025 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, May 29, 2025 | EXAMINERS AMENDMENT E-MAILED |
| Friday, May 30, 2025 | ASSIGNED TO LIE |
| Friday, May 30, 2025 | EXAMINER'S AMENDMENT ENTERED |
| Friday, May 30, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, May 16, 2025 | NEW REPRESENTATIVE AT IB RECEIVED |